Matthew J. Rioth

Also affiliated with Technology Holding (United States)

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 3 papers. Top paper: “Seven decades of chemotherapy clinical trials: a pan-cancer social network analysis”.

Seven decades of chemotherapy clinical trials: a pan-cancer social network analysis

Scientific Reports(2020)10.1038/s41598-020-73466-6

N/A

0DataRank · unranked

4 citations

Elizabeth A. Sigworth, Adrianne H. Wu, Jess Behrens, Shervin Etemad, Seema Nagpal +28 more

Expanding the landscape of oncogenic drivers and treatment options in acral and mucosal melanomas by targeted genomic profiling

International Journal of Cancer(2024)10.1002/ijc.35087

N/A

0DataRank · unranked

5 citations

Robert J. Van Gulick, William A. Robinson, Tariq I. Mughal, Richard P. Tobin, Morgan MacBeth +22 more

Feasibility of RECIST-based real-world tumor response assessment in metastatic non-small cell lung cancer patients.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e21121

N/A

0DataRank · unranked

0 citations

Alan Fu, Monika A. Izano, Liz Toland, Ryan Hilbelink, Huakang Tu +5 more